The FDA issued a notice identifying a high-risk device issue associated with a Medtronic recall of Bravo CF capsule delivery ...

The Food and Drug Administration published an early alert for the recall on Tuesday. No deaths have been associated with the ...

FDA highlights risks from recalled Medtronic devices tied to esophageal injuries and faulty cannulas, with serious health ...

Investors are increasingly eyeing the fast-growing MedSurg equipment space, which is projected to witness a compound annual growth rate (CAGR) of 9.54% from 2025 to 2030 (per Grand View Research). Two ...

Medtronic received Food and Drug Administration approval for the BrainSense Adaptive deep brain stimulation (DBS) device for people with Parkinson’s disease, a movement disorder of the nervous ...

Medtronic Inc. said Tuesday that it is paying $200 million in cash for a Dutch company that is working on a next-generation deep-brain stimulation device for patients with neurodegenerative diseases.

A deep brain stimulation device used to treat conditions like Parkinson's disease was classified Thursday by the U.S. Food and Drug Administration as a Class I recall — meaning the FDA believes ...

Medtronic has published preliminary data from a study of its adaptive deep brain stimulation (aDBS) device, Percept PC neurostimulator, in patients living with Parkinson’s disease. The adaptive ...

The device — called Percept™ RC neurostimulator— is the latest advancement in deep brain stimulation (DBS) technology from Medtronic, a global leader in healthcare technology that has ...